Novartis Pharmaceuticals Corporation

Registered Principal Details

Cessation Date
6/2/2014 3:16:00 PM

Business Or Interest:
All matters affecting pharmaceutical manufacturing and health care.

Lobbying Interests:
Mental health issues; drug pricing issues; health care reform; access; coverage; budgets.

CEO Name:
Andre Wyss
Executive Director

Contact
GS
Gregory Slyfield
One Health Plaza, Building 701/433
East Hanover, NJ 07936
(862) 778-6664
(973) 781-6671
gregory.slyfield@novartis.com
http://www.novartis.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Lisa Steelman Exclusive Duties N/A Authorized On 12/5/2012 Withdrawn On 6/2/2014

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 392
Assembly Bill 392
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)

Bill Text and History

Other
Notification Date
2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 445
Assembly Bill 445
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)

Bill Text and History

2013 Wisconsin Act 199

Other
Notification Date
2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 448
Assembly Bill 448
Relating to: programs for the disposal of drugs, including controlled substances, and certain medical or drug-related items, and the regulation of prescription drugs. (FE)

Bill Text and History

2013 Wisconsin Act 198

Other
Notification Date
2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 300
Senate Bill 300
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)

Bill Text and History

2013 Wisconsin Act 186

For
Notification Date
10/16/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 351
Senate Bill 351
Relating to: programs for the disposal of drugs, including controlled substances, and certain medical or drug-related items, and the regulation of prescription drugs. (FE)

Bill Text and History

Other
Notification Date
2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 353
Senate Bill 353
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)

Bill Text and History

Other
Notification Date
2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

LRB−1961/1: Health Benefit Exchange (Craig) Requiring legislation for agencies to take an action to, request federal moneys to, and use state moneys to assist the federal government to create or implement a health benefits exchange
Development, drafting or introduction of a proposal relating to
LRB−1961/1: Health Benefit Exchange (Craig) Requiring legislation for agencies to take an action to, request federal moneys to, and use state moneys to assist the federal government to create or implement a health benefits exchange

Action Intended To Affect
Legislative matter

Notification Date
10/25/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

LRB-3279/1. Medical Assistance (Sanfelippo) Mental health benefits and reimbursement for mental health services under the Medical Assistance program Position: Monitoring
Development, drafting or introduction of a proposal relating to
LRB-3279/1. Medical Assistance (Sanfelippo) Mental health benefits and reimbursement for mental health services under the Medical Assistance program Position: Monitoring

Action Intended To Affect
Legislative matter

Notification Date
10/16/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2013
January - June
2013
July - December
2014
January - June
Total
Total Lobbying Expenditures 2013
January - June
$2,771.52
2013
July - December
$5,797.33
2014
January - June
$4,082.62
Total $12,651.46
Total Hours Communicating 2013
January - June
0.00
2013
July - December
0.00
2014
January - June
0.00
Total 0.00
Total Hours Other 2013
January - June
19.50
2013
July - December
35.50
2014
January - June
25.00
Total 80.00

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: identification presentation and monitoring for certain prescription drugs. (FE)
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
2014
January - June
5 %
2014
July - December
Total 1 %
Relating to: programs for the disposal of drugs, including controlled substances, and certain medical or drug-related items, and the regulation of prescription drugs. (FE)
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
2014
January - June
5 %
2014
July - December
Total 1 %
Relating to: programs for the disposal of drugs, including controlled substances, and certain medical or drug-related items, and the regulation of prescription drugs. (FE)
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
2014
January - June
5 %
2014
July - December
Total 1 %
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
2014
January - June
5 %
2014
July - December
Total 1 %
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
2014
January - June
15 %
2014
July - December
Total 5 %
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
2014
January - June
15 %
2014
July - December
Total 5 %

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

No topics found.

Minor Efforts

No minor efforts found.

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
100 %
2013
July - December
100 %
2014
January - June
50 %
2014
July - December
Total 84 %

Filed Statements of Lobbying Activity and Expenditures